M.D. Sass LLC’s iShares MSCI ACWI ex US ETF ACWX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.93M Sell
57,340
-3,260
-5% -$230K 0.3% 31
2025
Q4
$4.07M Hold
60,600
0.32% 30
2025
Q3
$3.94M Sell
60,600
-1,660
-3% -$104K 0.32% 33
2025
Q2
$3.79M Buy
62,260
+500
+0.8% +$28.9K 0.31% 31
2025
Q1
$3.42M Buy
61,760
+12,660
+26% +$695K 0.3% 29
2024
Q4
$2.56M Hold
49,100
0.19% 32
2024
Q3
$2.81M Hold
49,100
0.21% 32
2024
Q2
$2.61M Buy
49,100
+6,000
+14% +$320K 0.19% 31
2024
Q1
$2.3M Hold
43,100
0.26% 31
2023
Q4
$2.2M Hold
43,100
0.26% 28
2023
Q3
$2.03M Buy
43,100
+7,300
+20% +$357K 0.27% 27
2023
Q2
$1.76M Hold
35,800
0.23% 28
2023
Q1
$1.75M Hold
35,800
0.22% 28
2022
Q4
$1.63M Buy
35,800
+4,000
+13% +$175K 0.24% 25
2022
Q3
$1.27M Hold
31,800
0.23% 27
2022
Q2
$1.43M Sell
31,800
-10,500
-25% -$508K 0.27% 25
2022
Q1
$2.21M Hold
42,300
0.38% 26
2021
Q4
$2.35M Hold
42,300
0.37% 29
2021
Q3
$2.34M Hold
42,300
0.4% 28
2021
Q2
$2.43M Sell
42,300
-4,200
-9% -$241K 0.4% 30
2021
Q1
$2.57M Hold
46,500
0.45% 28
2020
Q4
$2.47M Hold
46,500
0.53% 28
2020
Q3
$2.14M Sell
46,500
-4,400
-9% -$203K 0.53% 28
2020
Q2
$2.2M Buy
50,900
+13,000
+34% +$531K 0.58% 30
2020
Q1
$1.43M Hold
37,900
0.52% 30
2019
Q4
$1.86M Buy
37,900
+3,000
+9% +$143K 0.44% 34
2019
Q3
$1.61M Buy
34,900
+6,400
+22% +$293K 0.38% 35
2019
Q2
$1.33M Hold
28,500
0.31% 45
2019
Q1
$1.32M Hold
28,500
0.21% 46
2018
Q4
$1.2M Hold
28,500
0.2% 43
2018
Q3
$1.36M Hold
28,500
0.18% 44
2018
Q2
$1.35M Buy
+28,500
New +$1.41M 0.17% 42

Other funds holding ACWX

M.D. Sass LLC's ACWX Position: Q1 2026 in Review

M.D. Sass LLC reduced its iShares MSCI ACWI ex US ETF (ACWX) stake by 5.4% in Q1 2026, selling an estimated $230K and leaving 57,340 shares worth $3.93M. The position accounts for 0.3% of the portfolio, ranked #31.

M.D. Sass LLC first reported a position in ACWX in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.07M in Q4 2025. 701 funds tracked by Wall St. Rank hold ACWX as of Q1 2026.

  • M.D. Sass LLC held 57,340 shares of iShares MSCI ACWI ex US ETF worth $3.93M as of Q1 2026.
  • M.D. Sass LLC sold 3,260 iShares MSCI ACWI ex US ETF shares in Q1 2026, an estimated $230K.
  • iShares MSCI ACWI ex US ETF made up 0.3% of M.D. Sass LLC's portfolio in Q1 2026, its #31 holding.
  • M.D. Sass LLC first reported a position in iShares MSCI ACWI ex US ETF in Q2 2018 and has held it in 32 quarters since.
  • M.D. Sass LLC's iShares MSCI ACWI ex US ETF position peaked at $4.07M in Q4 2025.
  • 701 funds tracked by Wall St. Rank held iShares MSCI ACWI ex US ETF as of Q1 2026.

Based on M.D. Sass LLC's 13F filing for Q1 2026, filed 14 May 2026.